Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
JCI Insight
|
November 16, 2018
Early expansion of donor-specific Tregs in tolerant kidney transplant recipients
Thomas M Savage, Brittany A Shonts, Aleksandar Obradovic, et al.
Journal of Hepatology
|
September 2, 2017
Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder
Vincent Mallet, Julie Bruneau, Julien Zuber, et al.
Kidney International
|
March 30, 2012
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
Aude Servais, Laure-Hélène Noël, Lubka T Roumenina, et al.
Transplantation
|
January 24, 2017
Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program
Lucile Amrouche, Olivier Aubert, Caroline Suberbielle, et al.
Science Immunology
|
February 28, 2017
Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome
Julien Zuber, Brittany Shonts, Sai-Ping Lau, et al.
Kidney International
|
April 14, 2022
Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
Nathalie Chavarot, Clea Melenotte, Lucile Amrouche, et al.
The Journal of Pathology
|
April 3, 2025
Histologic and molecular features shared between antibody-mediated rejection of kidney allografts and chronic histiocytic intervillositis support common pathogenesis
Léonie Albersammer, Juliette Leon, Jelena Martinovic, et al.
Transplantation Direct
|
November 10, 2025
Long-term Graft and Patient Survival in Kidney Transplant Recipients With High Levels of Preformed DSAs (MFI > 3000): A Propensity Score-matched Analysis
Charlotte Debiais-Deschamps, Lucile Amrouche, Marion Rabant, et al.
Journal of the American Society of Nephrology : JASN
|
February 15, 2022
CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant Recipients
Baptiste Lamarthée, Carole Burger, Charlotte Leclaire, et al.
Transplantation
|
April 8, 2021
Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept
Nathalie Chavarot, Amani Ouedrani, Olivier Marion, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
JCI Insight
|
November 16, 2018
Early expansion of donor-specific Tregs in tolerant kidney transplant recipients
Thomas M Savage, Brittany A Shonts, Aleksandar Obradovic, et al.
Journal of Hepatology
|
September 2, 2017
Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder
Vincent Mallet, Julie Bruneau, Julien Zuber, et al.
Kidney International
|
March 30, 2012
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
Aude Servais, Laure-Hélène Noël, Lubka T Roumenina, et al.
Transplantation
|
January 24, 2017
Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program
Lucile Amrouche, Olivier Aubert, Caroline Suberbielle, et al.
Science Immunology
|
February 28, 2017
Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome
Julien Zuber, Brittany Shonts, Sai-Ping Lau, et al.
Kidney International
|
April 14, 2022
Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection
Nathalie Chavarot, Clea Melenotte, Lucile Amrouche, et al.
The Journal of Pathology
|
April 3, 2025
Histologic and molecular features shared between antibody-mediated rejection of kidney allografts and chronic histiocytic intervillositis support common pathogenesis
Léonie Albersammer, Juliette Leon, Jelena Martinovic, et al.
Transplantation Direct
|
November 10, 2025
Long-term Graft and Patient Survival in Kidney Transplant Recipients With High Levels of Preformed DSAs (MFI > 3000): A Propensity Score-matched Analysis
Charlotte Debiais-Deschamps, Lucile Amrouche, Marion Rabant, et al.
Journal of the American Society of Nephrology : JASN
|
February 15, 2022
CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant Recipients
Baptiste Lamarthée, Carole Burger, Charlotte Leclaire, et al.
Transplantation
|
April 8, 2021
Poor Anti-SARS-CoV-2 Humoral and T-cell Responses After 2 Injections of mRNA Vaccine in Kidney Transplant Recipients Treated With Belatacept
Nathalie Chavarot, Amani Ouedrani, Olivier Marion, et al.
Page
of 12